来自官方财务报表的收入、利润与现金流历史。
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
| 利润表 | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 总收入 | $3.1B | $2.9B | $2.5B | $1.6B | $1.0B | $958M | $789M | $785M | $713M | $636M | $564M | $545M | $474M | $434M | $386M | $331M | $288M | $254M |
| 毛利 | $2.2B | $2.0B | $1.5B | $1.0B | $759M | $719M | $572M | $605M | $554M | $486M | $429M | $412M | $364M | $334M | $311M | $263M | $234M | $213M |
| 毛利率% | 68.5% | 67.4% | 58.9% | 65.0% | 74.2% | 75.0% | 72.4% | 77.1% | 77.6% | 76.3% | 76.1% | 75.7% | 76.6% | 76.9% | 80.5% | 79.2% | 81.3% | 83.6% |
| 营业利润（EBIT） | $667M | $480M | $166M | $133M | $228M | $172M | $111M | $172M | $169M | $162M | $154M | $172M | $138M | $102M | $115M | $97M | $88M | $82M |
| 营业利润率% | 21.2% | 16.3% | 6.6% | 8.5% | 22.3% | 17.9% | 14.1% | 21.9% | 23.8% | 25.4% | 27.3% | 31.6% | 29.2% | 23.4% | 29.7% | 29.4% | 30.4% | 32.2% |
| 净利 | $536M | $538M | $103M | $123M | $190M | $149M | $102M | $155M | $156M | $107M | $104M | $113M | $92M | $69M | $74M | $61M | $54M | $49M |
| 净利润率 % | 17.0% | 18.3% | 4.1% | 7.8% | 18.6% | 15.6% | 13.0% | 19.8% | 21.9% | 16.9% | 18.5% | 20.7% | 19.5% | 15.8% | 19.1% | 18.3% | 18.9% | 19.2% |
| EBITDA | — | $730M | $474M | $347M | $305M | $265M | $178M | $229M | $219M | $205M | $193M | $196M | $160M | $121M | $133M | $116M | $106M | $97M |
| 每股收益（EPS） | $3.90 | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 | $1.01 | $1.52 | $1.54 | $1.10 | $1.08 | $1.17 | $0.97 | $0.73 | $0.80 | $0.81 | $0.72 | $0.54 |
| 已发行股数 (M) | — | 137M | 138M | 115M | 103M | 104M | 101M | 102M | 101M | 98M | 96M | 96M | 95M | 94M | 92M | 75M | 75M | 91M |
来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。
资产负债表、现金流、季度数据与完整财务比率见 GMED 交互式查看器。 /companies/us/GMED
本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。
About TickerBase · Data methodology & sources · Privacy · Terms